Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors

Clinical trial NCT04266912 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04266912
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Malignant Solid Neoplasm Refractory Malignant Solid Neoplasm Unresectable Malignant Solid Neoplasm

Start date: 2020-03-17
Primary completion: 2024-11-13
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.